-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Case-control studies have clearly plasma homocysteine is venous thrombosis embolism (VTE) risk marker.
thrombus
Recently, the heart blood vessels published a research article in the authoritative magazine on the field of Arteriosclerosis, Thrombosis, and Vascular Biology, researchers analyzed two large prospective cohort of female plasma homocysteine is associated with venous thromboembolic events.
Heart blood vessels
The Women’s Health Study (WHS) is a prospective cohort study that included 27,555 women over 45 years of age without cardiovascular disease and venous thromboembolism.
Correlation between homocysteine and VTE
In age-corrected analysis, elevated levels of homocysteine, hsCRP (high-sensitivity c-reactive protein), fibrinogen, and sICAM-1 (soluble intercellular adhesion molecule 1) were associated with VTE events (extreme quartile comparison P <0.
It can be seen that elevated plasma homocysteine levels are related to venous thromboembolism events in middle-aged and elderly women.
Elevated plasma homocysteine levels are associated with venous thromboembolic events in middle-aged and elderly women.
Original source:
Aaron W.